Agrify Corp AGFY
We take great care to ensure that the data presented and summarized in this overview for Agrify Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AGFY
View allLatest Institutional Activity in AGFY
Top Purchases
Top Sells
About AGFY
Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.
Insider Transactions at AGFY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 03
2024
|
David Aaron Kessler Chief Science Officer |
SELL
Open market or private sale
|
Direct |
13,598
-30.84%
|
$516,724
$38.92 P/Share
|
Dec 03
2024
|
Timothy Mahoney Director |
SELL
Open market or private sale
|
Direct |
1,097
-100.0%
|
$46,074
$42.69 P/Share
|
Dec 03
2024
|
Max Holtzman Director |
SELL
Open market or private sale
|
Direct |
1,097
-86.46%
|
$46,074
$42.2 P/Share
|
Dec 03
2024
|
Brian Towns EVP - Extraction |
SELL
Open market or private sale
|
Direct |
5,282
-4.75%
|
$211,280
$40.12 P/Share
|
Nov 28
2024
|
Krishnan Varier Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,097
+50.0%
|
-
|
Nov 28
2024
|
David Aaron Kessler Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,597
+50.0%
|
-
|
Nov 28
2024
|
Timothy Mahoney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,097
+50.0%
|
-
|
Nov 28
2024
|
Brian Towns EVP - Extraction |
BUY
Exercise of conversion of derivative security
|
Direct |
13,597
+50.0%
|
-
|
Nov 28
2024
|
Max Holtzman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,097
+50.0%
|
-
|
Nov 22
2024
|
Benjamin Kovler Interim CEO |
BUY
Open market or private purchase
|
Indirect |
840
+50.0%
|
$36,960
$44.81 P/Share
|
Nov 22
2024
|
Benjamin Kovler Interim CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+25.0%
|
$225,000
$45.89 P/Share
|
Nov 20
2024
|
Benjamin Kovler Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
Nov 05
2024
|
Raymond Nobu Chang > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
38
-100.0%
|
-
|
Nov 05
2024
|
Raymond Nobu Chang > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
462,673
-100.0%
|
-
|
Nov 05
2024
|
I Tseng Jenny Chan > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
203,991
-100.0%
|
-
|
Aug 30
2024
|
Raymond Nobu Chang > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,022,830
+41.21%
|
-
|
Aug 30
2024
|
I Tseng Jenny Chan > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,724,070
+36.04%
|
-
|
Feb 28
2024
|
Raymond Nobu Chang > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,842,104
+35.85%
|
$0
$0.38 P/Share
|
Jan 25
2024
|
I Tseng Jenny Chan > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,335,816
+50.0%
|
$1,335,816
$1.46 P/Share
|
Jan 25
2024
|
Raymond Nobu Chang > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,335,817
+47.88%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 10K shares |
---|---|
Open market or private purchase | 1.85M shares |
Exercise of conversion of derivative security | 30.5K shares |
Conversion of derivative security | 8.42M shares |
Open market or private sale | 688K shares |
---|